Biotech, and bioprocessing more specifically, is a great place to be. But it's time for a new adventure.
China's regulators acknowledge the quality gap, and have a plan for steady improvement.
Good leaders look beyond industry woes to focus on patients
Industry and regulators disagree over noncritical parameters.